Results 141 to 150 of about 895 (178)

Risicofactoren, diagnose en behandeling van (azole-resistente) invasieve aspergillose [PDF]

, 2020
Schauwvlieghe, Alexander
core  

Trends of Azole-Resistant Aspergillus Fumigatus Susceptibility Over 12 Years from a German ECMM Excellence Center. [PDF]

Mycopathologia
Verhasselt HL, Thissen L, Scharmann U, Dittmer S, Rath PM, Steinmann J, Kirchhoff L.   +6 more
europepmc   +1 more source

Recent innovations and challenges in the treatment of fungal infections. [PDF]

Front Cell Infect Microbiol
Liu D, Zhou R, Gao X.
europepmc   +1 more source

Drug Discovery and Repurposing for <i>Coccidioides</i>: A Systematic Review. [PDF]

J Fungi (Basel)
Saeger S, Lozano S, Wiederhold N, Yu JJ, Lopez-Ribot JL, Hung CY.   +5 more
europepmc   +1 more source

Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases – a debate

Hoenigl, Martin, Lass-Flörl, Cornelia, Maertens, Johan, Richardson, Malcolm, Slavin, Monica, THOMPSON III, George R.   +5 more
core   +3 more sources

Elevated mutation rates in multi-azole resistant Aspergillus fumigatus drive rapid evolution of antifungal resistance. [PDF]

Nat Commun
Bottery MJ, van Rhijn N, Chown H, Rhodes JL, Celia-Sanchez BN, Brewer MT, Momany M, Fisher MC, Knight CG, Bromley MJ.   +9 more
europepmc   +1 more source

Spectrum of clinically significant melanized fungi in NIH hospitalized patients and their antifungal susceptibility profiles. [PDF]

Med Mycol
Vitale RG, de Hoog S, Stock F, Scudder C, Shahegh SE, Aneke CI, Tolooe A, Fennelly KP, Lionakis MS, Kwon-Chung J, Seyedmousavi A.   +10 more
europepmc   +1 more source

Characteristics of individual <i>cyp51A</i> SNPs and combinations thereof impacting the azole phenotype in TR₃₄-mediated resistance genotypes of <i>Aspergillus fumigatus</i>. [PDF]

Antimicrob Agents Chemother
Song Y, Buil JB, Zoll J, Tehupeiory-Kooreman M, Venselaar H, Li R, Melchers WJG, Verweij PE.   +7 more
europepmc   +1 more source